Cleared Traditional

K150512 - STAR 90

K150512 is an FDA 510(k) clearance for STAR 90, manufactured by Skanray Technologies Pvt, Ltd.. The device is a Class 2 Cardiovascular device with product code MWI cleared through the Traditional 510(k) pathway after a 110-day FDA review.

K150512 · Skanray Technologies Pvt, Ltd. · Cardiovascular device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Jun 2015
Decision
110d
Days
Class 2
Risk

K150512 is an FDA 510(k) clearance for the STAR 90. Classified as Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms) (product code MWI), Class II - Special Controls.

Submitted by Skanray Technologies Pvt, Ltd. (Mysore, IN). The FDA issued a Cleared decision on June 17, 2015 after a review of 110 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2300 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Skanray Technologies Pvt, Ltd. devices

FDA 510(k) Submission Details - K150512

510(k) Number K150512 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 27, 2015
Decision Date June 17, 2015
Days to Decision 110 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
15d faster than avg
Panel avg: 125d · This submission: 110d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

MWI Device Classification - Class 2, Special Controls

Product Code MWI Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2300
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Consultant

Smith Assoicates
Yolanda Smith

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - MWI Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms)

All 307
Devices cleared under the same product code (MWI) and FDA review panel - the closest regulatory comparables to K150512.
T3 Software
K151715 · Etiometry, Inc. · Oct 2015
Tempus IC2
K152124 · Remote Diagnostics Technologies, Ltd. · Oct 2015
SmartLinx Vitals Plus Patient Monitoring System
K151071 · Capsule Technologie Sas · Sep 2015
Sickbay Clinical Platform
K143304 · Medical Informatics Corp · May 2015
Datalys Multi-Parameter Patient Monitor
K150691 · Lutech Industries, Inc. · May 2015
740 SELECT
K150620 · Cas Medical Systems, Inc. · May 2015